Obesity and Thrombosis (Q22252221)

2

R C

Sam

1 reference

8 February 2023

S.H. Silverman

3

S H

Silverman

1 reference

8 February 2023

A.W. Bradbury

4

A W

Bradbury

1 reference

8 February 2023

D.J. Adam

5

D J

European Journal of Vascular and Endovascular Surgery

Adam

1 reference

8 February 2023

language of work or name

English

0 references

publication date

February 2007

0 references

published in

0 references

volume

33

0 references

page(s)

223-233

0 references

issue

2

0 references

cites work

Overweight, obesity, and health risk

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Body mass index and the risk of stroke in men.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

A prospective study of risk factors for pulmonary embolism in women

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

A prospective study of body mass index, weight change, and risk of stroke in women.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Elevated C-reactive protein levels in overweight and obese adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Platelet activation in obese women: role of inflammation and oxidant stress

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Plasma adiponectin levels and risk of myocardial infarction in men.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Effect of weight on claudication distance

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Interrelations between carbohydrates, lipids, and the hemostatic system in relation to the risk of thrombotic and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Tissue-plasminogen activator, plasminogen activator inhibitor and risk of peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Obesity as a cardiovascular risk factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Serum total 8-iso-prostaglandin F2alpha: a new and independent predictor of peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

C-reactive protein in peripheral arterial disease: relation to severity of the disease and to future cardiovascular events

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Association of C-reactive protein with markers of prevalent atherosclerotic disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Lipoprotein (a) and development of intermittent claudication and major cardiovascular events in men and women: the Edinburgh Artery Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

1 reference

7 January 2021

Congenital leptin deficiency is associated with severe early-onset obesity in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

A novel pathway to the manifestations of metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Relationship of obesity distribution and peripheral arterial occlusive disease in elderly men

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Oxidant stress: a key determinant of atherothrombosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Body mass index is associated with the development of the post-thrombotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

1 reference

7 January 2021

Obesity and cardiovascular disease: pathogenic mechanisms and potential benefits of weight reduction

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Adiponectin stimulates production of nitric oxide in vascular endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Correlates of markers of oxidative status in the general population

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Factors associated with oxidative stress in human populations

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Association of fibrinogen and coagulation factors VII and VIII with cardiovascular risk factors in the elderly: the Cardiovascular Health Study. Cardiovascular Health Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

The relationship between cigarette smoking and cardiovascular risk factors in peripheral arterial disease compared with ischaemic heart disease. The Edinburgh Artery Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Peripheral vascular disease: consequence for survival and association with risk factors in the Speedwell prospective heart disease study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Central obesity, insulin resistance, syndrome X, lipoprotein(a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Diabetes, lipids, and adipocyte secretagogues

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

High leptin levels are associated with stroke.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

The insulin resistance syndrome: implications for thrombosis and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Vascular inflammation and the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Association of hypoadiponectinemia with coronary artery disease in men

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Obesity and oxidative stress: a direct link to CVD?

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

The adipocyte and hemostatic balance in obesity: studies of PAI-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the pathophysiology of obesity-associated cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Body mass index: a risk factor for unstable angina and myocardial infarction in patients with angiographically confirmed coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Direct effects of gemfibrozil on the fibrinolytic system. Diminution of synthesis of plasminogen activator inhibitor type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Elaboration of type-1 plasminogen activator inhibitor from adipocytes. A potential pathogenetic link between obesity and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Obesity is associated with tissue-specific activation of renal angiotensin-converting enzyme in vivo: evidence for a regulatory role of endothelin

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Abdominal obesity and risk of ischemic stroke: the Northern Manhattan Stroke Study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Increased oxidative stress in obesity and its impact on metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Stroke: epidemiology, clinical picture, and risk factors--Part I of III.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Obesity as the core of the metabolic syndrome and the management of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Prevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: the METS-GREECE Multicentre Study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Adipose tissue as an endocrine organ

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Adiponectin as a biomarker of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Production of Plasminogen Activator Inhibitor 1 by Human Adipose Tissue: Possible Link Between Visceral Fat Accumulation and Vascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Leptin promotes aggregation of human platelets via the long form of its receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Association between adiponectin and mediators of inflammation in obese women.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Prevalence of the metabolic syndrome in middle-aged men and women

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021

The role of leptin in human obesity and disease: a review of current evidence

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJVS.2006.10.006

7 January 2021